Detalhe da pesquisa
1.
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Lancet
; 403(10429): 850-859, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364841
2.
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.
Ann Rheum Dis
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782549
3.
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Ann Rheum Dis
; 83(6): 706-719, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499325
4.
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
J Rheumatol
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621793
5.
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
Ann Rheum Dis
; 82(1): 57-64, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109139
6.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
7.
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients.
J Autoimmun
; 135: 102996, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642057
8.
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.
Rheumatology (Oxford)
; 62(10): 3268-3279, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727470
9.
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.
Clin Exp Rheumatol
; 41(3): 543-553, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916322
10.
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years.
Mod Rheumatol
; 33(1): 64-72, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365828
11.
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Mod Rheumatol
; 33(4): 657-667, 2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921235
12.
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years.
Ann Rheum Dis
; 81(2): 184-192, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740884
13.
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database.
Ann Rheum Dis
; 81(3): 335-343, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706874
14.
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Ann Rheum Dis
; 81(5): 695-709, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972811
15.
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis.
Rheumatology (Oxford)
; 61(6): 2596-2602, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508594
16.
Purinergic signalling in systemic sclerosis.
Rheumatology (Oxford)
; 61(7): 2770-2782, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849624
17.
Treatment of relapsing polychondritis: a systematic review.
Clin Exp Rheumatol
; 40 Suppl 134(5): 81-85, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238756
18.
Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis.
Clin Exp Rheumatol
; 40 Suppl 134(5): 86-92, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238768
19.
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.
Clin Exp Rheumatol
; 40 Suppl 134(5): 71-80, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238758
20.
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
Clin Exp Rheumatol
; 40 Suppl 134(5): 3-11, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349419